TREA

79427536 - EXORNEASY

Follow

Information

  • Trademark
  • 79427536
  • Serial Number
    79427536
  • Filing Date
    April 04, 2025
    9 months ago
  • Transaction Date
    July 25, 2025
    5 months ago
  • Status Date
    July 24, 2025
    5 months ago
  • Location Date
    July 24, 2025
    5 months ago
  • Status Code
    638
  • Current Location
    TMO LAW OFFICE 122
    Employee Name
    BLAZICH,JOAN MICHELE
  • Law Office Assigned Location Code
    N40
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EXORNEASY
Case File Statements
  • GS0091: Laboratory apparatus and instruments; scientific apparatuses, instruments and devices, as well as their parts and components included in this class; tubes, pipette tips, chromatographic columns; spin columns; membranes for filtration (scientific), affinity and size exclusion chromatography (SEC); spin column membranes; bottles and vessels for laboratory use; laboratory storage and collecting tubes; holders for test tubes; software for use in scientific and medical research; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, in particular for use in the purification, isolation and/or analysis of nucleic acids, including DNA, RNA, mRNA, miRNA, and extracellular vesicles, such as exosomes, and their molecular constituents like proteins, nucleic acids and lipids; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, for use in analysis and determination of quality and quantity of vesicles; laboratory filters; membranes including ultrafiltration and adsorption membranes, for laboratory apparatus; filters for biological samples, including cell cultures and their supernatants, blood and blood components for laboratory use; scientific apparatuses, instruments and devices, including disposable equipment, components and parts thereof, in particular for use in purification, isolation and/ or analysis of vesicles from biological samples, in particular biofluids, including urine, serum, plasma, cerebrospinal fluid (CSF) and cell culture supernatant.
  • GS0051: Chemical, biochemical and biotechnological products for medical and veterinary purposes; chemical, biochemical and biotechnological products for human in-vitro diagnostic purposes; chemical, biochemical and biotechnological reagents and preparations for human in-vitro diagnostic purposes; kits comprising chemical, biochemical and biotechnological products for human in vitro diagnostic; chemical, biochemical and biotechnological products for medical and pharmaceutical research; kits comprising chemical products for human in-vitro diagnostic for medical or pharmaceutical purposes; kits comprising chemical, biochemical and biotechnological products for human in vitro diagnostic for detection of pathogens, viruses and bacteria for medical or pharmaceutical purposes; diagnostic preparations for medical and veterinary purposes, namely diagnostics preparations for marking, separating, isolating, purification and/or for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and their molecular constituents like proteins, lipids and nucleic acids, including DNA, RNA, mRNA, miRNA; diagnostic reagents, enzymes and buffer solutions for purification isolation and analysis of extracellular vesicles and nucleic acid for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, separating, isolating, purification and/or for the analysis of biopolymers, in particular extracellular vesicles and their molecular constituents like nucleic acids, proteins and lipids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, in particular for marking, separating, isolating, purification and/or for the analysis of biopolymers, in particular extracellular vesicles, nucleic acids, including DNA, RNA, mRNA, miRNA, proteins and lipids; diagnostic kits containing reagents, enzymes and buffer solutions for purification and isolation of extracellular vesicles and their molecular constituents and nucleic acid isolation, amplification and analysis for medical or veterinary purposes.
  • GS0011: Chemical, biochemical and biotechnological products for use in industry or research use; chemical, biochemical and biotechnological products for non-medical purposes; chemical, biochemical and biotechnological products for use in in vitro-diagnostic for non-medical purposes; chemical, biochemical and biotechnological products for use in scientific and laboratory research; chemical, biochemical and biotechnological products for use in in-vitro diagnostic for scientific research or laboratory use; chemical, biochemical and biotechnological reagents and preparations for use in scientific and laboratory research; kits comprising chemical, biochemical and biotechnological products for industrial and scientific purposes; kits comprising chemical, biochemical and biotechnological products for use in in-vitro diagnostic for non-medical purposes; non-medical reagents, enzymes and chemicals, used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, purification and/or for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and their molecular constituents like proteins, lipids and nucleic acids, including DNA, RNA, mRNA, miRNA, in particular reagents, enzymes and buffer solutions for purification, isolation and analysis of extracellular vesicles and nucleic acids; chemical test kits for laboratory or research use for marking, separating, isolating and/or for the analysis of biopolymers, in particular extracellular vesicles such as exosomes and nucleic acids, in particular comprising reagents, enzymes and buffer solutions for analysis.
Case File Event Statements
  • 7/24/2025 - 5 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/11/2025 - 5 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/10/2025 - 6 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 7/11/2025 - 5 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS